Arbutus Biopharma Corp Quarterly Return On Equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arbutus Biopharma Corp quarterly/annual Return On Equity history and growth rate from Q3 2014 to Q3 2024.
  • Arbutus Biopharma Corp Return On Equity for the quarter ending September 30, 2024 was -68.2 %, a 20.8% decline year-over-year.
  • Arbutus Biopharma Corp annual Return On Equity for 2023 was -57.8 %, a 25.2% decline from 2022.
  • Arbutus Biopharma Corp annual Return On Equity for 2022 was -46.2 %, a 22.1% increase from 2021.
  • Arbutus Biopharma Corp annual Return On Equity for 2021 was -59.3 %, a 21.4% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -68.2 -11.7 -20.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -66.7 -14.7 -28.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -62.7 -14.3 -29.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -57.8 -11.6 -25.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -56.5 -13 -30% Jul 1, 2023 Sep 30, 2023
Q2 2023 -52 -6.46 -14.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -48.3 +5.08 +9.51% Jan 1, 2023 Mar 31, 2023
Q4 2022 -46.2 +13.1 +22.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -43.4 +21 +32.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -45.6 +23.6 +34.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -53.4 +16.5 +23.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -59.3 +16.2 +21.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -64.4 +28 +30.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -69.1 +114 +62.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -69.9 +76.6 +52.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -75.4 +47.1 +38.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -92.4 +1.19 +1.27% Jul 1, 2020 Sep 30, 2020
Q2 2020 -183 -136 -290% Apr 1, 2020 Jun 30, 2020
Q1 2020 -146 -116 -386% Jan 1, 2020 Mar 31, 2020
Q4 2019 -122 -96.7 -375% Oct 1, 2019 Dec 31, 2019
Q3 2019 -93.6 -59.2 -172% Jul 1, 2019 Sep 30, 2019
Q2 2019 -46.9 -16.8 -55.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -30.1 +13.8 +31.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -25.8 +21.5 +45.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 -34.4 +111 +76.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 -30.2 +81.6 +73% Apr 1, 2018 Jun 30, 2018
Q1 2018 -43.9 +80.9 +64.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -47.2 +49.5 +51.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -145 -110 -312% Jul 1, 2017 Sep 30, 2017
Q2 2017 -112 -77 -221% Apr 1, 2017 Jun 30, 2017
Q1 2017 -125 -113 -969% Jan 1, 2017 Mar 31, 2017
Q4 2016 -96.7 -86 -803% Oct 1, 2016 Dec 31, 2016
Q3 2016 -35.3 -21.7 -160% Jul 1, 2016 Sep 30, 2016
Q2 2016 -34.8 -22.6 -185% Apr 1, 2016 Jun 30, 2016
Q1 2016 -11.7 +3.22 +21.6% Jan 1, 2016 Mar 31, 2016
Q4 2015 -10.7 +28.7 +72.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -13.6 +25 +64.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -12.2 Apr 1, 2015 Jun 30, 2015
Q1 2015 -14.9 Jan 1, 2015 Mar 31, 2015
Q4 2014 -39.4 Oct 1, 2014 Dec 31, 2014
Q3 2014 -38.6 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.